JESSICA DINE: Open Payments
NPI 1073155719 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 96 payments from 22 companies in 2025. Trend: 2023 $1,770 · 2024 $1,523 · 2025 $1,728
Food & beverage: $1,474Education: $254
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $258 |
| Gilead Sciences, Inc. | 12 | $249 |
| Kowa Pharmaceuticals America, Inc. | 18 | $243 |
| Amgen Inc. | 19 | $148 |
| Otsuka America Pharmaceutical, Inc. | 7 | $148 |
| Lilly USA, LLC | 7 | $117 |
| Novo Nordisk Inc | 6 | $110 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $38 |
Products named: ZORYVE, REXULTI, JARDIANCE, EVENITY, Auvelity, FANAPT, OTEZLA, Wegovy.
Industry payments across TX — which companies pay providers there.
